Tech Company Financing Transactions
Allylix Funding Round
Allylix, based in San Diego, raised $18.2 million from BASF Venture Capital America, Cultivian Sandbox and private investors.
Transaction Overview
Company Name
Announced On
3/12/2012
Transaction Type
Venture Equity
Amount
$18,200,000
Round
Undisclosed
Investors
BASF Venture Capital America (Lead Investor) (Daniela Proske)
Proceeds Purpose
This round of funding will support the development and delivery of new renewable specialty chemicals in Allylix's pipeline, as well as allow us to expand the market segments for our existing products.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
7220 Trade St. 209
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Allylix has developed proprietary technology that allows it to produce a group of natural products called terpenes at low cost.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carolyn Fritz
VP - Bus. Development
Seth Goldblum
VP - R & D
Richard Burlingame
Browse more venture capital transactions:
Prev: 3/12/2012: LensAR venture capital transaction
Next: 3/12/2012: HemaQuest Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs